The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More
A novel adjuvant technology for use in vaccines and in antibody production that gives excellent immune responses with low manufacturing costs, and can be administered by a variety of routes More
Direct thrombin inhibitors designed for improved safety/efficacy profile. Peptide inhibitors suitable for cost-effective recombinant production.Anti-thrombin peptides that can be fused to homing peptides for targeted delivery or fused to markers. More
A method to generate microorganisms showing high-yield synthesis of 6-hydroxynicotinic acid (6-HNA, a precursor of pharmaceuticals, agrochemicals and feed) based on genetic engineering More
All rights reserved. Terms and Conditions | Contact us
